Table of Content

Part 1. Introduction
1.1 Market definition
1.2 Key benefits
1.3 Market segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive summary

Part 4. Market overview
4.1 Introduction
4.2 Market dynamics
4.2.1 Drivers
4.2.2 Restraints

Part 5. Global market for anticoagulants by drug class
5.1 Novel oral anticoagulants (NOACs)
5.1.1 Market size and forecast
5.2 Heparin and low-molecular weight heparin (LMWH)
5.2.1 Market size and forecast
5.3 Vitamin K antagonist
5.3.1 Market size and forecast

Part 6. Global market for anticoagulants by application
6.1 Atrial fibrillation/myocardial infarction (heart attack)
6.1.1 Market size and forecast
6.2 Deep vein thrombosis (DVT)
6.2.1 Market size and forecast
6.3 Pulmonary embolism (PE)
6.3.1 Market size and forecast
6.4 Others
6.4.1 Market size and forecast

Part 7. Global market for anticoagulants by region
7.1 Asia Pacific
7.1.1 Market size and forecast
7.2 Europe
7.2.1 Market size and forecast
7.3 North America
7.3.1 Market size and forecast
7.4 Rest of the World (RoW)
7.4.1 Market size and forecast

Part 8. Key competitor profiles
8.1 Alexion Pharmaceuticals, Inc.
8.2 Aspen Pharmacare Holdings Limited
8.3 Bayer AG
8.4 Boehringer Ingelheim Pharmaceuticals Inc.
8.5 Bristol-Myers Squibb Company
8.6 Daiichi Sankyo Company, Limited
8.7 Dr. Reddy’s Laboratories Ltd.
8.8 Johnson & Johnson
8.9 LEO Pharma A/S
8.10 Pfizer Inc.
8.11 Sanofi SA
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

DISCLAIMER
ABOUT GEN CONSULTING COMPANY